Filter
168
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
22
New Publications
50
Language
Document type
No document type
86
Studies & Reports
33
Guidelines
20
Strategic & Response Plan
13
Manuals
8
Training Material
2
Situation Updates
2
Resource Platforms
2
Fact sheets
2
Countries / Regions
Ethiopia
10
Kenya
9
India
7
Global
6
Uganda
5
Zambia
4
Africa
4
Sierra Leone
3
Nigeria
3
Philippines
3
Nepal
3
South Sudan
3
Rwanda
3
South Africa
3
Liberia
2
Senegal
2
Ghana
2
Tanzania
2
Malawi
2
Eswatini/ Swaziland
2
Ukraine
2
Western and Central Europe
2
Congo, Democratic Republic of
1
Cameroon
1
Haiti
1
Pakistan
1
Syria
1
Cambodia
1
Indonesia
1
Bangladesh
1
Mozambique
1
Sudan
1
Namibia
1
South–East Asia Region
1
Fiji
1
Eastern Europe
1
Timor Leste/ East Timor
1
Lithuania
1
Authors & Publishers
Publication Years
Category
Countries
75
Key Resources
13
Clinical Guidelines
8
Public Health
5
Pharmacy & Technologies
4
Women & Child Health
2
Capacity Building
1
Toolboxes
AMR
16
Pharmacy
14
COVID-19
10
HIV
9
Mental Health
8
NTDs
8
TB
7
Disability
4
Planetary Health
4
Conflict
3
Health Financing Toolbox
3
NCDs
3
Ebola & Marburg
2
Rapid Response
2
Specific Hazards
2
Global Health Education
2
Caregiver
2
Natural Hazards
1
Refugee
1
Zika
1
Malaria
1
2.0 Rapid Response
1
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o
...
La publication fournit une vue d'ensemble et une analyse des instruments internationaux qui établissent des normes relatives à l'utilisation des antimicrobiens dans les secteurs humain, animal et végétal, et à leur rejet dans l'environnement. L'objectif de ce document est d'identifier les instr
...
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
Version 2 (unedited). The Basic Needs Analysis (BNA) is a multi-sector needs analysis approach that can be applied in both sudden onset and protracted emergencies. The methodology comprises the Guidance (this document) presenting the conceptual BNA framework and related processes, and a Toolbox, whi
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...
WHO Secretariat Information paper July 2016
Depression is a leading cause of non-fatal disease burden worldwide, with a lifetime prevalence of 9% among European adult men and 17% among European adult women.
The task at hand requires substantial investments in preventive mental health care, but the potential benefits can be equally rewarding.
...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
